Literature DB >> 22811834

Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.

Dongyun Yang1, Andrew Hendifar, Cosima Lenz, Kayo Togawa, Felicitas Lenz, Georg Lurje, Alexandra Pohl, Thomas Winder, Yan Ning, Susan Groshen, Heinz-Josef Lenz.   

Abstract

BACKGROUND: Despite the success of modern chemotherapy in the treatment of large bowel cancers, patients with metastatic gastric cancer continue to have a dismal outcome. Identifying predictive and prognostic markers is an important step to improving current treatment approaches and extending survival.
METHODS: Extracting data from the US NCI's Surveillance, Epidemiology, and End Results (SEER) registries, we compared overall survival for patients with metastatic gastric cancer by gender, age, and ethnicity using Cox proportional hazards models. 13,840 patients (≥ 18 years) were identified from 1988-2004. Males and females were categorized by age grouping and ethnicity.
RESULTS: 19% of Hispanic patients were diagnosed < 45 years of age as compared to 5.5% of Caucasians. Caucasian patients and men were more likely to be diagnosed with tumors in the gastric cardia (P<0.001). In our survival analysis, we found that women had a lower risk of dying as compared to men (P<0.001). Overall survival diminished with age (P<0.001). The median overall survival was 6 months in patients of ≤ 44 years old as compared to 3 months in patients 75 years and older. Gender differences in overall survival significantly varied by race and tumor grade/differentiation (P for interaction = 0.003 and 0.005, respectively).
CONCLUSION: This is the largest study of metastatic gastric cancer patients from the SEER registry to show that age, gender, and tumor location are significant independent prognostic factors for overall survival in patients with metastatic gastric cancer.

Entities:  

Keywords:  age; ethnicity; gastric cancer; gender; survival

Year:  2011        PMID: 22811834      PMCID: PMC3397601          DOI: 10.3978/j.issn.2078-6891.2010.025

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  40 in total

1.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

2.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

3.  Gastric carcinoma in patients younger than age 36 years.

Authors:  E Holburt; S I Freedman
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

4.  Is the prognosis for Japanese and German patients with gastric cancer really different?

Authors:  E Bollschweiler; K Boettcher; A H Hoelscher; M Sasako; T Kinoshita; K Maruyama; J R Siewert
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

5.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.

Authors:  S S Devesa; W J Blot; J F Fraumeni
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.

Authors:  J Y Wang; J S Hsieh; C J Huang; Y S Huang; T J Huang
Journal:  J Surg Oncol       Date:  1996-09       Impact factor: 3.454

8.  Gastric carcinoma in the young.

Authors:  P L Tso; W L Bringaze; A H Dauterive; P Correa; I Cohn
Journal:  Cancer       Date:  1987-04-01       Impact factor: 6.860

9.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Authors:  L Coussens; T L Yang-Feng; Y C Liao; E Chen; A Gray; J McGrath; P H Seeburg; T A Libermann; J Schlessinger; U Francke
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

10.  Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.

Authors:  C C Abnet; N D Freedman; F Kamangar; M F Leitzmann; A R Hollenbeck; A Schatzkin
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

View more
  84 in total

1.  Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.

Authors:  Yuanhong Xu; Zhe Liu; Kejian Guo
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

2.  Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.

Authors:  Anuradha Vasista; Martin Stockler; Andrew Martin; Nick Pavlakis; Katrin Sjoquist; David Goldstein; Sanjeev Gill; Vikram Jain; Geoffrey Liu; George Kannourakis; Yeul Hong Kim; Louise Nott; Stephanie Snow; Matthew Burge; Dean Harris; Derek Jonker; Yu Jo Chua; Richard Epstein; Antony Bonaventura; Belinda Kiely
Journal:  Oncologist       Date:  2019-04-01

3.  Twist expression associated with the epithelial-mesenchymal transition in gastric cancer.

Authors:  Ai-ning Liu; Zhi-Hua Zhu; Shu-jian Chang; Xiao-sheng Hang
Journal:  Mol Cell Biochem       Date:  2012-05-13       Impact factor: 3.396

4.  Examining the gastric cancer survival gap between Asians and whites in the United States.

Authors:  Hongbin Jin; Paulo S Pinheiro; Karen E Callahan; Sean F Altekruse
Journal:  Gastric Cancer       Date:  2016-11-19       Impact factor: 7.370

Review 5.  Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview.

Authors:  Miguel Alberto; Andreas Brandl; Pankaj Kumar Garg; Safak Gül-Klein; Mathias Dahlmann; Ulrike Stein; Beate Rau
Journal:  Clin Exp Metastasis       Date:  2019-02-04       Impact factor: 5.150

6.  Gastric cancer drug trials - are women second class citizens?

Authors:  Lishi Wang; Yan Jiao; Yun Jiao; Yanhong Cao; Weikuan Gu
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

7.  Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.

Authors:  S Bremholm Ellebæk; M Graversen; S Detlefsen; L Lundell; C W Fristrup; P Pfeiffer; M B Mortensen
Journal:  Clin Exp Metastasis       Date:  2020-01-30       Impact factor: 5.150

8.  Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.

Authors:  Wan Kyu Eo; Da Wun Jeong; Hye Jung Chang; Kyu Yeoun Won; Sung Il Choi; Se Hyun Kim; Sung Wook Chun; Young Lim Oh; Tae Hwa Lee; Young Ok Kim; Ki Hyung Kim; Yong Il Ji; Ari Kim; Heung Yeol Kim
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

9.  Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial.

Authors:  Gianluca Tomasello; Wanda Liguigli; Rossana Poli; Silvia Lazzarelli; Matteo Brighenti; Federica Negri; Alessandra Curti; Mario Martinotti; Lucio Olivetti; Massimo Rovatti; Gianvito Donati; Rodolfo Passalacqua
Journal:  Gastric Cancer       Date:  2013-11-27       Impact factor: 7.370

10.  An Investigation into the Recent Increase in Gastric Cancer in the USA.

Authors:  Maya Balakrishnan; Rollin George; Ashish Sharma; David Y Graham; Hoda M Malaty
Journal:  Dig Dis Sci       Date:  2018-03-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.